Clinical Trials & Research

Driven to apply our scientific insights to develop medicines that improve the lives of patients with rare metabolic disorders.


Selecta Biosciences is a clinical stage biotechnology company with a commitment to solving the challenges associated with autoimmunity and unwanted immunogenicity through our pioneering ImmTOR® precision immune tolerance platform.

Select Language